Compare Centrus Energy Corp (LEU) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs Twist Bioscience Corp — how do they compare? Centrus Energy Corp trades at $171.22 (market cap $3.08B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Twist Bioscience Corp is the larger of the two by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals.
| LEU | TWST | |
|---|---|---|
Market Cap | $3.08B | $5.45B |
Sector | Energy | Health |
52-Week High | $436.00 | $102.88 |
52-Week Low | $146.61 | $24.16 |
Enterprise Value | $2.39B | $5.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $156.39, showing modest daily gains amid a bearish technical signal. The company reported mixed quarterly earnings, with a recent beat in Q1 2026 but misses in prior quarters. Recent positive developments include a $1 billion Department of Energy contract and inclusion in the S&P SmallCap 600 index, highlighting its strategic role in the nuclear fuel supply chain. Valuation ratios appear elevated with a P/E of 56.87, while profitability metrics like a 13.4% net income margin indicate solid operational performance.
The outlook for LEU is cautiously optimistic, driven by government contracts and nuclear industry tailwinds, but high valuation and earnings volatility pose risks. Analyst consensus leans bullish with a $223.14 price target, though technical indicators suggest near-term pressure. Investors should weigh growth potential against execution risks and market sentiment shifts.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
